Join HESI OASIS Consortium members David Rouquie (Bayer) and Jessica Ewald (Broad Institute) for an exciting installment of the DyNAMic Discussions webinar series, where experts share their experiences in overcoming barriers to applying New Approach Methodologies (NAMs) in their fields. This seminar series offers candid perspectives on how we can collectively increase NAM adoption.
Speakers:
Dr. David Rouquie, Bayer. OASIS: a multi-stakeholder collaboration leveraging robust omics data to evaluate liver toxicity.
Dr. Jessica Ewald, Broad Institute. Cell Painting as an emerging omics’ tool for toxicology and drug discovery.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.